Wegovy Injection Pen – 2.4 mg x 4 Doses (Semaglutide)

Wegovy Injection Pen contains semaglutide, a medication that mimics the naturally occurring hormone GLP-1 (glucagon-like peptide-1), which plays a key role in regulating appetite and glucose metabolism. By activating GLP-1 receptors in the brain, semaglutide reduces hunger, increases satiety, and slows gastric emptying, helping patients control food intake more effectively.

The 2.4 mg dose is the final maintenance step in the structured Wegovy dose-escalation program, designed to maximize therapeutic effects while maintaining tolerability. This dosage is generally used after patients have successfully progressed through all prior lower-dose phases.

The pen is pre-filled for once-weekly subcutaneous injection, making it a convenient option for home use as part of a comprehensive weight management plan.

Maximized appetite control
Semaglutide helps regulate hunger and increase fullness, supporting reduced calorie intake.

Supports long-term weight management
By controlling appetite and food intake, the medication may facilitate gradual and sustainable weight loss.

Highest maintenance dose
The 2.4 mg dose provides the strongest therapeutic effect in the Wegovy treatment schedule.

Convenient weekly injection
Pre-filled pen allows for simple and reliable once-weekly administration.

Promotes metabolic health
Improved appetite regulation and glucose metabolism may support overall long-term metabolic balance.

Wegovy (Semaglutide) Injection Pen – 2.4 mg is administered as a subcutaneous injection once per week.

General usage guidelines:

• Inject once weekly on the same day each week.

• The injection can be administered with or without food.

• Recommended injection sites include the abdomen, thigh, or upper arm.

• Rotate injection sites to reduce irritation.

• Follow the dosing schedule and instructions provided by your healthcare professional.

The 2.4 mg dose is typically used after completing the 0.25 mg, 0.5 mg, 1 mg, and 1.7 mg starting and escalation phases, forming the final maintenance step in the Wegovy program.

For optimal results, treatment should be combined with healthy eating habits, portion control, and regular physical activity.

Wegovy (Semaglutide) should only be used under the supervision of a healthcare professional.

Important precautions:

• Common side effects may include nausea, vomiting, diarrhea, constipation, or decreased appetite.

• Inform your healthcare provider about existing medical conditions or medications before starting treatment.

• Individuals with a personal or family history of thyroid disorders should consult a healthcare professional before use.

• Do not use if allergic to semaglutide or any components of the formulation.

• Store the injection pen according to manufacturer instructions, typically refrigerated until use.

If severe side effects or allergic reactions occur, discontinue use and seek medical attention immediately.